| scholarly article | Q13442814 |
| P50 | author | Jody Corey-Bloom | Q50848575 |
| Leon J. Thal | Q56839882 | ||
| P2093 | author name string | L. A. Hansen | |
| L A Hansen | |||
| P Tiraboschi | |||
| P. Tiraboschi | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1984-1989 | |
| 1984-9 | |||
| P577 | publication date | 2004-06-07 | |
| 2004-06-08 | |||
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The importance of neuritic plaques and tangles to the development and evolution of AD | |
| P478 | volume | 62 |
| Q35208143 | "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? |
| Q28828212 | A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition |
| Q38862070 | A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery |
| Q36385926 | A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease |
| Q35005568 | A review of creatine supplementation in age-related diseases: more than a supplement for athletes |
| Q35106666 | A systematic review of single chinese herbs for Alzheimer's disease treatment |
| Q30455082 | APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). |
| Q38073067 | Advances in microfluidics-based experimental methods for neuroscience research |
| Q57792155 | Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET |
| Q37700238 | Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease |
| Q92874248 | Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study |
| Q47094454 | Alzheimer disease neuropathology: understanding autonomic dysfunction |
| Q36713885 | Alzheimer's disease protein Abeta1-42 does not disrupt isolated synaptic vesicles |
| Q37785311 | Alzheimer's secretases regulate voltage-gated sodium channels |
| Q27009411 | Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease |
| Q37698159 | Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults |
| Q33775494 | Amyloid load in nondemented brains correlates with APOE e4. |
| Q60530541 | Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis |
| Q34070840 | An efficient approach for differentiating Alzheimer's disease from normal elderly based on multicenter MRI using gray-level invariant features |
| Q33536493 | Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Abeta42 and Alzheimer's disease neuropathology |
| Q34007682 | Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease |
| Q53333346 | Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. |
| Q58609478 | Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan |
| Q38247994 | Autophagy and neurodegenerative disorders |
| Q48884122 | Beta-amyloid induced changes in A-type K⁺ current can alter hippocampo-septal network dynamics. |
| Q34310255 | Beta-amyloid oligomers activate apoptotic BAK pore for cytochrome c release. |
| Q50928336 | Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. |
| Q37915439 | Casting a net on dendritic spines: the extracellular matrix and its receptors |
| Q92638553 | Changes in visual function and retinal structure in the progression of Alzheimer's disease |
| Q37035800 | Characterization of Japanese-American men with a single neocortical AD lesion type |
| Q33670849 | Characterizing amyloid‐beta protein misfolding from molecular dynamics simulations with explicit water |
| Q48558378 | Clearing the fog: patenting trends for the treatment of Alzheimer's disease |
| Q34554590 | Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity |
| Q36691131 | Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes |
| Q37180132 | Coexisting cholinergic and parahippocampal degeneration: a key to memory loss in dementia and a challenge for transgenic models? |
| Q34061233 | Cognition, glucose metabolism and amyloid burden in Alzheimer's disease |
| Q36575903 | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature |
| Q33389200 | Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? |
| Q38199058 | Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases |
| Q38807264 | DYRK1A inhibition as potential treatment for Alzheimer's disease. |
| Q36787352 | Dementia syndromes: evaluation and treatment |
| Q38109214 | Developmental neuroplasticity and the origin of neurodegenerative diseases |
| Q36380210 | Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brains |
| Q47555988 | Differentiating between Alzheimer Disease Patients and Controls with Phase-difference-enhanced Imaging at 3T: A Feasibility Study |
| Q43427045 | Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease |
| Q47260966 | Disrupted functional connectivity between perirhinal and parahippocampal cortices with hippocampal subfields in patients with mild cognitive impairment and Alzheimer's disease |
| Q33993507 | Effect size of reference memory deficits in the Morris water maze in Tg2576 mice |
| Q90477691 | Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration |
| Q64263723 | Epigenetic Modifications in Alzheimer's Neuropathology and Therapeutics |
| Q34543638 | Expression of α-subunit of α-glucosidase II in adult mouse brain regions and selected organs |
| Q64121571 | GeneAnalytics Pathways and Profiling of Shared Autism and Cancer Genes |
| Q35686013 | Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran |
| Q41960357 | Heavy metals and neurodegenerative diseases: an observational study |
| Q35855414 | Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease |
| Q48416807 | Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice |
| Q64244115 | Identification and Analysis of Alzheimer's Candidate Genes by an Amplitude Deviation Algorithm |
| Q47665108 | Identification of a small set of plasma signalling proteins using neural network for prediction of Alzheimer's disease |
| Q51911405 | Imaging dementing illnesses. |
| Q48326005 | Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly |
| Q64080477 | Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis |
| Q47556778 | Impact of social relationships on Alzheimer's memory impairment: mechanistic studies |
| Q36967181 | In vitro and in vivo study of effects of fermented soybean product (chungkookjang) on NGF secretion ability and NGF receptor signaling pathway |
| Q64988218 | Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling. |
| Q37813015 | Interleukin-1β with learning and memory |
| Q64054840 | Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline |
| Q34776816 | Is there a neuropathology difference between mild cognitive impairment and dementia? |
| Q30366183 | Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. |
| Q92543632 | Linking the low-density lipoprotein receptor-binding segment enables the therapeutic 5-YHEDA peptide to cross the blood-brain barrier and scavenge excess iron and radicals in the brain of senescent mice |
| Q36958569 | MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. |
| Q39153824 | Main Plant Extracts' Active Properties Effective on Scopolamine-Induced Memory Loss |
| Q38870841 | Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers |
| Q38151704 | Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders |
| Q38187044 | Mercury toxicity and neurodegenerative effects |
| Q35349339 | Mining disease genes using integrated protein-protein interaction and gene-gene co-regulation information |
| Q33828911 | Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons |
| Q26783344 | Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal |
| Q35228880 | Monodisperse carboxyl-functionalized poly(ethylene glycol)-coated magnetic poly(glycidyl methacrylate) microspheres: application to the immunocapture of β-amyloid peptides |
| Q37559812 | Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease |
| Q26825619 | N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease |
| Q40867620 | NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide |
| Q38388660 | Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly |
| Q33288482 | Neuropathological findings processed by artificial neural networks (ANNs) can perfectly distinguish Alzheimer's patients from controls in the Nun Study |
| Q36496131 | Neuropathological quantification of dtg APP/PS1: neuroimaging, stereology, and biochemistry |
| Q37218110 | Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship |
| Q61449183 | Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease |
| Q58130251 | New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies |
| Q38170010 | New insight into neurodegeneration: the role of proteomics |
| Q46979323 | Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease. |
| Q35993835 | Ocular manifestations of Alzheimer's disease in animal models. |
| Q30572288 | Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement |
| Q60957194 | Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases |
| Q37421024 | Oxidative stress and neurodegenerative disorders |
| Q33783748 | Pathways for small molecule delivery to the central nervous system across the blood-brain barrier |
| Q90215258 | Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases |
| Q36576018 | Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function |
| Q36962319 | Potential role of PCTAIRE-2, PCTAIRE-3 and P-Histone H4 in amyloid precursor protein-dependent Alzheimer pathology |
| Q36298571 | Prediction and classification of Alzheimer disease based on quantification of MRI deformation |
| Q60960925 | Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI |
| Q34354478 | Probable Early-Onset Alzheimer’s Disease in an Apolipoprotein E2 Homozygote |
| Q35223610 | Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model |
| Q37644772 | Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease |
| Q38468247 | Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease |
| Q37553976 | Protein SUMOylation in neuropathological conditions. |
| Q41869540 | Protein kinase C-regulated aβ production and clearance |
| Q38746607 | Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells |
| Q91771264 | RNA Granules and Their Role in Neurodegenerative Diseases |
| Q64243648 | Random forest prediction of Alzheimer's disease using pairwise selection from time series data |
| Q38061634 | Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's? |
| Q39613391 | Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study |
| Q38435275 | Registering eye movements during reading in Alzheimer's disease: difficulties in predicting upcoming words |
| Q34438729 | Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study |
| Q35581060 | Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. |
| Q36418108 | Role of ABC transporters in the pathogenesis of Alzheimer's disease |
| Q38659590 | Role of Apolipoproteins and α-Synuclein in Parkinson's Disease. |
| Q37922607 | Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases |
| Q87404860 | Role of pH in structural changes for Pin1 protein: an insight from molecular dynamics study |
| Q26783370 | SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease? |
| Q49096980 | Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model |
| Q36115392 | Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance |
| Q48248565 | Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis. |
| Q47799714 | Sumoylation: Implications for Neurodegenerative Diseases |
| Q37783348 | Synthesis and transport of creatine in the CNS: importance for cerebral functions |
| Q38812439 | T-type Ca(2+) channels: New players in the aging brain |
| Q90450363 | The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease |
| Q37544199 | The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism |
| Q34159126 | The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases. |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q38563230 | The impact of base excision DNA repair in age-related neurodegenerative diseases |
| Q33652461 | The importance of hydrogen bonding between the glutamine side chains to the formation of amyloid VQIVYK parallel beta-sheets: an ONIOM DFT/AM1 study |
| Q30441452 | The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults |
| Q37038726 | The role of DNA repair in brain related disease pathology |
| Q35551001 | The role of environmental exposures in neurodegeneration and neurodegenerative diseases |
| Q33943520 | Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations |
| Q28082768 | Three dimensions of the amyloid hypothesis: time, space and 'wingmen' |
| Q48485666 | Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain |
| Q35861900 | Tract-based analysis of white matter degeneration in Alzheimer's disease. |
| Q37253034 | Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects |
| Q37352964 | Transglutaminase activation in neurodegenerative diseases. |
| Q38874015 | Ubiquitin-dependent and independent roles of SUMO in proteostasis |
| Q38039079 | Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence |
| Q34418781 | Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models |
| Q99240291 | Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-β Pathology |
| Q89766852 | β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates |
| Q60191481 | „Default-mode“-Netzwerk des Gehirns |
Search more.